Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: RECOMBINANT PROTEINS - THERAPEUTIC USE , . Treffer: 43

2016

Kash, N; Massone, C; Fink-Puches, R; Cerroni, L Phenotypic Variation in Different Lesions of Mycosis Fungoides Biopsied Within a Short Period of Time From the Same Patient.
Am J Dermatopathol. 2016; 38(7):541-545 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2015

Petru, E; Singer, CF; Polterauer, S; Galid, A; Schauer, C; Klocker, J; Seifert, M; Reinthaller, A; Benedicic, C; Hubalek, M; Hefler, L; Marth, C; Scholl-Firon, T; Bogner, G; Zeimet, AG Prophylactic long-acting granulocyte-colony stimulating factors (G-CSF) in gynecologic malignancies: an oncologic expert statement.
Wien Med Wochenschr. 2015; 165(19-20):387-394
Web of Science PubMed FullText FullText_MUG

 

2014

Mandorfer, M; Neukam, K; Rivero, A; Puoti, M; Boesecke, C; Baumgarten, A; Grzeszczuk, A; Zangerle, R; Ernst, D; Rockstroh, JK; Trauner, M; Pineda, JA; Peck-Radosavljevic, M; Reiberger, T Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapy.
Antivir Ther. 2014; 19(4):407-414
Web of Science PubMed FullText FullText_MUG

 

Mandorfer, M; Payer, BA; Scheiner, B; Breitenecker, F; Aichelburg, MC; Grabmeier-Pfistershammer, K; Rieger, A; Trauner, M; Peck-Radosavljevic, M; Reiberger, T Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin.
Liver Int. 2014; 34(1): 69-77.
Web of Science PubMed FullText FullText_MUG

 

Mandorfer, M; Reiberger, T; Payer, BA; Breitenecker, F; Aichelburg, MC; Obermayer-Pietsch, B; Rieger, A; Puoti, M; Zangerle, R; Trauner, M; Peck-Radosavljevic, M Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels.
J Viral Hepat. 2014; 21(1):33-41
Web of Science PubMed FullText FullText_MUG

 

Stättermayer, AF; Rutter, K; Beinhardt, S; Wrba, F; Scherzer, TM; Strasser, M; Hofer, H; Steindl-Munda, P; Trauner, M; Ferenci, P Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C.
Liver Int. 2014; 34(3):388-395
Web of Science PubMed FullText FullText_MUG

 

2013

Grangl, G; Gallistl, S; Leschnik, B; Muntean, W Port-A-Cath infection causes inhibitor recurrence after initial successful ITI.
Haemophilia. 2013; 19(3):e174-e175 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Kruit, WH; Suciu, S; Dreno, B; Mortier, L; Robert, C; Chiarion-Sileni, V; Maio, M; Testori, A; Dorval, T; Grob, JJ; Becker, JC; Spatz, A; Eggermont, AM; Louahed, J; Lehmann, FF; Brichard, VG; Keilholz, U Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment of Cancer Melanoma Group in Metastatic Melanoma.
J Clin Oncol. 2013; 31(19): 2413-2420. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mandorfer, M; Reiberger, T; Payer, BA; Ferlitsch, A; Breitenecker, F; Aichelburg, MC; Obermayer-Pietsch, B; Rieger, A; Trauner, M; Peck-Radosavljevic, M; Vienna HIV & Liver Study Group Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
AIDS. 2013; 27(2):227-232 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Scherzer, TM; Stättermayer, AF; Stauber, R; Maieron, A; Strasser, M; Laferl, H; Schwarzer, R; Datz, C; Rutter, K; Beinhardt, S; Steindl-Munda, P; Hofer, H; Ferenci, P Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients.
J Hepatol. 2013; 59(5):964-971
Web of Science PubMed FullText FullText_MUG

 

2012

Wahn, V; Aberer, W; Eberl, W; Fasshauer, M; Kuhne, T; Kurnik, K; Magerl, M; Meyer-Olson, D; Martinez-Saguer, I; Spath, P; Staubach-Renz, P; Kreuz, W; Hereditary angioedema (HAE) in children and adolescents-a consensus on therapeutic strategies.
Eur J Pediatr. 2012; 171(9):1339-1348 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Henke, M; Alfonsi, M; Foa, P; Giralt, J; Bardet, E; Cerezo, L; Salzwimmer, M; Lizambri, R; Emmerson, L; Chen, MG; Berger, D Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
J CLIN ONCOL. 2011; 29(20): 2815-2820. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Le, QT; Kim, HE; Schneider, CJ; Murakozy, G; Skladowski, K; Reinisch, S; Chen, Y; Hickey, M; Mo, M; Chen, MG; Berger, D; Lizambri, R; Henke, M Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
J CLIN ONCOL. 2011; 29(20): 2808-2814. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Scherzer, TM; Stättermayer, AF; Strasser, M; Laferl, H; Maieron, A; Stauber, R; Datz, C; Dulic-Lakovic, E; Steindl-Munda, P; Hofer, H; Ferenci, P Impact of IL28B on treatment outcome in hepatitis C virus G1/4 patients receiving response-guided therapy with peginterferon alpha-2a (40KD)/ribavirin.
HEPATOLOGY. 2011; 54(5): 1518-1526. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2010

Schlegel, N; Bardet, V; Kenet, G; Muntean, W; Zieger, B; Nowak-Gottl, U Diagnostic and therapeutic considerations on inherited platelet disorders in neonates and children.
KLIN PADIAT. 2010; 222(3): 209-214.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2009

Auerswald, G; Muntean, W; Kemkes-Matthes, B; Klamroth, R; Krause, M; Kurnik, K; Oldenburg, J; Pabinger-Fasching, I; Schramm, W; Zimmermann, R; Zotz, RB Relevance of a single dose of 270 microg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors - Recommendations from the GTH experts
Hamostaseologie. 2009; 29(2): 197-203.
PubMed

 

Dutton, R; Hauser, C; Boffard, K; Dimsitts, J; Bernard, G; Holcomb, J; Leppäniemi, A; Tortella, B; Bouillon, B; CONTROL Steering Committee Scientific and logistical challenges in designing the CONTROL trial: recombinant factor VIIa in severe trauma patients with refractory bleeding.
Clin Trials. 2009; 6(5): 467-479.
Web of Science PubMed FullText FullText_MUG

 

Hofer, S; Rosenhagen, C; Nakamura, H; Yodoi, J; Bopp, C; Zimmermann, JB; Goebel, M; Schemmer, P; Hoffmann, K; Schulze-Osthoff, K; Breitkreutz, R; Weigand, MA Thioredoxin in human and experimental sepsis.
Crit Care Med. 2009; 37(7):2155-2159
Web of Science PubMed FullText FullText_MUG

 

2008

Harmatz, P; Giugliani, R; Schwartz, IV; Guffon, N; Teles, EL; Miranda, MC; Wraith, JE; Beck, M; Arash, L; Scarpa, M; Ketteridge, D; Hopwood, JJ; Plecko, B; Steiner, R; Whitley, CB; Kaplan, P; Yu, ZF; Swiedler, SJ; Decker, C; MPS VI Study Group Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase.
Mol Genet Metab. 2008; 94(4):469-475
Web of Science PubMed FullText FullText_MUG

 

2006

Schippinger, W; Holub, R; Dandachi, N; Bauernhofer, T; Samonigg, H Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim.
Oncology. 2006; 70(4):290-293
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2000

Brodmann, M; Stark, G; Pabst, E; Lueger, A; Pilger, E Pulmonary embolism and intracardiac thrombi--individual therapeutic procedures.
VASC MED. 2000; 5(1): 27-31. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Krepler, K; Kruger, A; Tittl, M; Stur, M; Wedrich, A Intravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration.
RETINA-J RETIN VITR DIS 2000 20: 251-256.
Web of Science PubMed FullText FullText_MUG

 

1998

Hermann, J; Walmsley, M; Brennan, FM Cytokine therapy in rheumatoid arthritis.
Springer Semin Immunopathol. 1998; 20(1-2):275-288
Web of Science PubMed FullText FullText_MUG

 

Zenz, W; Bodó, Z; Zobel, G; Fanconi, S; Rettenbacher, A Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
Crit Care Med. 1998; 26(5):969-971 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

1997

Kurz, Ch; Marth, Ch; Windbichler, G; Lahousen, M; Medl, M; Vavra, N; Sevelda, P Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study.
Gynecol Oncol. 1997; 65(3):461-466
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1996

Beitzke, A; Zobel, G; Zenz, W; Gamillscheg, A; Stein, JI Catheter-directed thrombolysis with recombinant tissue plasminogen activator for acute pulmonary embolism after fontan operation.
Pediatr Cardiol. 1996; 17(6):410-412 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Bostrom, M; Lane, JM; Tomin, E; Browne, M; Berberian, W; Turek, T; Smith, J; Wozney, J; Schildhauer, T Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model.
Clin Orthop Relat Res. 1996; 17(327): 272-282.
Web of Science PubMed FullText FullText_MUG

 

Zach, MS The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.
Thorax. 1996; 51(7):750-755 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

1995

Wasler, A; Iberer, F; Auer, T; Petutschnigg, B; Müller, H; Pfeifer, J; Deutsch, T; Tscheliessnigg, KH Treatment of leukopenia with granulocyte-macrophage colony-stimulating factor after heart transplantation.
Transplant Proc. 1995; 27(5):2633-2634
Web of Science PubMed

 

Zenz, W; Muntean, W; Gallistl, S; Zobel, G; Grubbauer, HM Recombinant tissue plasminogen activator treatment in two infants with fulminant meningococcemia.
Pediatrics. 1995; 96(1 Pt 1):144-148 (- Case Report)
Web of Science PubMed FullText Google Scholar

 

Zenz, W; Muntean, W; Zobel, G; Grubbauer, HM; Gallistl, S Treatment of fulminant meningococcemia with recombinant tissue plasminogen activator.
Thromb Haemost. 1995; 74(2):802-803 (- Case Report)
Web of Science PubMed Google Scholar

 

Zweiker, R; Eber, B; Kaufmann, P; Schumacher, M; Fruhwald, FM; Pokan, R; Klein, W Thrombolytic therapy of acute myocardial infarct in advanced age (based on 2 case reports)
Wien Klin Wochenschr. 1995; 107(6):202-205 (- Case Report)
Web of Science PubMed

 

1994

Ludwig, H; Fritz, E; Leitgeb, C; Pecherstorfer, M; Samonigg, H; Schuster, J Prediction of response to erythropoietin treatment in chronic anemia of cancer.
Blood. 1994; 84(4):1056-1063 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Pilger, E; Decrinis, M; Stark, G; Koch, G; Obernosterer, A; Tischler, R; Lafer, M; Doder, A Thrombolytic treatment and balloon angioplasty in chronic occlusion of the aortic bifurcation.
Ann Intern Med. 1994; 120(1):40-44 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1992

Link, H; Boogaerts, MA; Carella, AM; Ferrant, A; Gadner, H; Gorin, NC; Harabacz, I; Harousseau, JL; Hervé, P; Holldack, J; Linkesch, W; et al. A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma.
BLOOD. 1992; 80(9): 2188-2195. [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

1991

Graninger, WB; Hassfeld, W; Pesau, BB; Machold, KP; Zielinski, CC; Smolen, JS Induction of systemic lupus erythematosus by interferon-gamma in a patient with rheumatoid arthritis.
J Rheumatol. 1991; 18(10):1621-1622 (- Case Report)
Web of Science PubMed Google Scholar

 

Hausegger, KA; Lammer, J; Klein, GE; Flückiger, F; Lafer, M; Pilger, E; Aschauer, M Percutaneous recanalization of pelvic artery occlusions--fibrinolysis, PTA, stents
FORTSCHR RONTGENSTRAHL NEUEN. 1991; 155(6): 550-555.
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1990

Löw-Friedrich, I; Grützmacher, P; März, W; Bergmann, M; Schoeppe, W Long-term echocardiographic examinations in chronic hemodialysis patients substituted with recombinant human erythropoietin.
Blood Purif. 1990; 8(5):272-278
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1989

Eber, B The endothelium and antithrombotic substances
Acta Med Austriaca. 1989; 16(5):102-104
Web of Science PubMed

 

1988

Seewann, HL; Gastl, G; Lang, A; Abbrederis, K; Thaler, J; Flener, R; Huber, C Interferon-alpha-2 in the treatment of idiopathic myelofibrosis.
Blut. 1988; 56(4):161-163
Web of Science PubMed FullText FullText_MUG

 

1987

Ludwig, H; Linkesch, W; Gisslinger, H; Fritz, E; Sinzinger, H; Radaszkiewicz, T; Chott, A; Flener, R; Micksche, M Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.
Cancer Immunol Immunother. 1987; 25(3):266-273
Web of Science PubMed Google Scholar

 

Schwarzmeier, JD; Wagner, L; Prischl, F; Schwabe, M; Lion, T; Micksche, M; Köller, U; Bernhart, M; Fritz, O; Seewann, HL Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia
Klin Wochenschr. 1987; 65(14):699-705
Web of Science PubMed FullText FullText_MUG

 

1985

Linkesch, W; Gisslinger, H; Ludwig, H; Flener, R; Sinzinger, H Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses
Acta Med Austriaca. 1985; 12(5):123-127
Web of Science PubMed Google Scholar

 

© Med Uni Graz Impressum